Daniel Van Plew
2019
Compensation breakdown
Non-Equity Incentive Plan | $759,266 |
---|---|
Option Awards | $3,526,669 |
Salary | $683,100 |
Stock Awards | $2,840,008 |
Other | $20,470 |
Total | $7,829,513 |
Van Plew received $3.5M in option awards, accounting for 45% of the total pay in 2019.
Van Plew also received $759.3K in non-equity incentive plan, $683.1K in salary, $2.8M in stock awards and $20.5K in other compensation.
Rankings
In 2019, Daniel Van Plew's compensation ranked 1,133rd out of 13,971 executives tracked by ExecPay. In other words, Van Plew earned more than 91.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,133 | 92nd |
Manufacturing | 393 | 93rd |
Chemicals And Allied Products | 118 | 95th |
Drugs | 94 | 95th |
Pharmaceutical Preparations | 71 | 95th |
Van Plew's colleagues
We found four more compensation records of executives who worked with Daniel Van Plew at Regeneron Pharmaceuticals in 2019.
2019
Leonard Schleifer
Regeneron Pharmaceuticals
Chief Executive Officer
2019
George Yancopoulos
Regeneron Pharmaceuticals
Chief Scientific Officer
2019
Andrew Murphy
Regeneron Pharmaceuticals
Executive Vice President, Research
2019
Robert Landry
Regeneron Pharmaceuticals
Chief Financial Officer
News
April 21, 2022
April 23, 2021
April 24, 2020
April 26, 2019